- Home
- NNNN vs ECC Comparison
NNNN vs ECC Comparison
Compare NNNN & ECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- ECC
- Stock Information
- Founded
- NNNN 2021
- ECC 2014
- Country
- NNNN Germany
- ECC United States
- Employees
- NNNN N/A
- ECC N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ECC
- Sector
- NNNN Health Care
- ECC
- Exchange
- NNNN Nasdaq
- ECC NYSE
- Market Cap
- NNNN 267.7M
- ECC N/A
- IPO Year
- NNNN 2025
- ECC N/A
- Fundamental
- Price
- NNNN $6.63
- ECC $7.99
- Analyst Decision
- NNNN
- ECC Buy
- Analyst Count
- NNNN 0
- ECC 2
- Target Price
- NNNN N/A
- ECC $10.50
- AVG Volume (30 Days)
- NNNN 32.8K
- ECC 1.6M
- Earning Date
- NNNN 01-01-0001
- ECC 05-20-2025
- Dividend Yield
- NNNN N/A
- ECC 22.53%
- EPS Growth
- NNNN N/A
- ECC N/A
- EPS
- NNNN 0.06
- ECC 0.76
- Revenue
- NNNN $8,185,146.00
- ECC $179,767,542.00
- Revenue This Year
- NNNN N/A
- ECC $24.07
- Revenue Next Year
- NNNN N/A
- ECC $8.43
- P/E Ratio
- NNNN $116.38
- ECC $10.45
- Revenue Growth
- NNNN 21.95
- ECC 29.26
- 52 Week Low
- NNNN $5.18
- ECC $6.54
- 52 Week High
- NNNN $7.82
- ECC $10.49
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- ECC 55.21
- Support Level
- NNNN N/A
- ECC $7.81
- Resistance Level
- NNNN N/A
- ECC $8.23
- Average True Range (ATR)
- NNNN 0.00
- ECC 0.13
- MACD
- NNNN 0.00
- ECC 0.08
- Stochastic Oscillator
- NNNN 0.00
- ECC 75.88
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.